ORIC (NASDAQ: ORIC) holder files notice to sell 7,000 shares of stock
Rhea-AI Filing Summary
ORIC Pharmaceuticals filed a notice that a shareholder plans to sell 7,000 shares of common stock through J.P. Morgan Securities LLC on Nasdaq, with an aggregate market value of $84,000. The filing lists 97,389,279 shares of common stock outstanding. The shares to be sold were acquired on 08/25/2016 by exercising stock options for cash on that same date.
Positive
- None.
Negative
- None.
FAQ
What does ORIC's Form 144 filing disclose?
How many ORIC shares are planned to be sold under this Form 144?
What is the aggregate market value of the ORIC shares to be sold?
When were the ORIC shares to be sold originally acquired?
How many ORIC shares are shown as outstanding in this filing?
On which exchange will the ORIC shares be sold and through which broker?